- Home
- SMSI vs LIXT Comparison
SMSI vs LIXT Comparison
Compare SMSI & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- LIXT
- Stock Information
- Founded
- SMSI 1982
- LIXT 2005
- Country
- SMSI United States
- LIXT United States
- Employees
- SMSI N/A
- LIXT N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- LIXT Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- LIXT Health Care
- Exchange
- SMSI Nasdaq
- LIXT Nasdaq
- Market Cap
- SMSI 15.3M
- LIXT 12.4M
- IPO Year
- SMSI 1995
- LIXT N/A
- Fundamental
- Price
- SMSI $0.77
- LIXT $5.42
- Analyst Decision
- SMSI Strong Buy
- LIXT
- Analyst Count
- SMSI 1
- LIXT 0
- Target Price
- SMSI $5.00
- LIXT N/A
- AVG Volume (30 Days)
- SMSI 130.5K
- LIXT 161.7K
- Earning Date
- SMSI 11-12-2025
- LIXT 11-11-2025
- Dividend Yield
- SMSI N/A
- LIXT N/A
- EPS Growth
- SMSI N/A
- LIXT N/A
- EPS
- SMSI N/A
- LIXT N/A
- Revenue
- SMSI $18,658,000.00
- LIXT N/A
- Revenue This Year
- SMSI N/A
- LIXT N/A
- Revenue Next Year
- SMSI $59.48
- LIXT N/A
- P/E Ratio
- SMSI N/A
- LIXT N/A
- Revenue Growth
- SMSI N/A
- LIXT N/A
- 52 Week Low
- SMSI $0.60
- LIXT $0.64
- 52 Week High
- SMSI $1.95
- LIXT $6.26
- Technical
- Relative Strength Index (RSI)
- SMSI 57.55
- LIXT 61.60
- Support Level
- SMSI $0.71
- LIXT $5.40
- Resistance Level
- SMSI $0.76
- LIXT $6.26
- Average True Range (ATR)
- SMSI 0.04
- LIXT 0.61
- MACD
- SMSI 0.01
- LIXT 0.10
- Stochastic Oscillator
- SMSI 63.04
- LIXT 64.71
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.